"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Fansidar Consumer (continued)
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Read the Fansidar (sulfadoxine and pyrimethamine) Side Effects Center for a complete guide to possible side effects
PRECAUTIONS: Consult your pharmacist.
Additional Fansidar Information
Fansidar - User Reviews
Report Problems to the Food and Drug Administration
Find out what women really need.